Nov 13 (Reuters) - ChromoGenics AB CHRO.ST :
* Q3 NET SALES FOR PERIOD AMOUNTED TO SEK 3.5 (14.0) MILLION
* Q3 OPERATING LOSS AMOUNTED TO SEK -14.4 (-19.4) MILLION
* NET SALES FOR CURRENT YEAR ARE THEREFORE EXPECTED TO BE
LOWER
THAN OUTCOME IN 2019
* COST SAVINGS HAVE HAD GREATEST IMPACT IN Q3
* CASH AND CASH EQUIVALENTS AMOUNTED TO SEK 21.3 (48.2)
MILLION ON
SEPTEMBER 30, 2020
* CHROMOGENICS' ORDER BACKLOG AMOUNTED TO SEK 5.4 MILLION AT
END
OF Q3
Source text for Eikon: ID:nWkr6c3qKt
Further company coverage: CHRO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785110;))